113 related articles for article (PubMed ID: 2749883)
21. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
[No Abstract] [Full Text] [Related]
22. Hepatitis C virus causing non-A, non-B hepatitis in plasmapheresis centre.
Zhang WH; Liu CB; Sun YD; Alter HJ; Shih JW
Lancet; 1990 Feb; 335(8685):353. PubMed ID: 1967785
[No Abstract] [Full Text] [Related]
23. [Comparison of 4 plasmapheresis procedures].
Wieding JU; Ullrich H; Neumeyer H
Beitr Infusionsther; 1991; 28():65-76. PubMed ID: 1725662
[TBL] [Abstract][Full Text] [Related]
24. Donor safety in plasmapheresis.
Lundsgaard-Hansen P
Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
[TBL] [Abstract][Full Text] [Related]
25. [Efficiency of mechanical plasmapheresis].
Matthes G; Pawlow I; Richter E
Beitr Infusionsther; 1991; 28():56-64. PubMed ID: 1725661
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulation, bleeding, and clotting at donor plasmapheresis.
Evers J; Taborski U
J Clin Apher; 2018 Aug; 33(4):538-540. PubMed ID: 29575131
[TBL] [Abstract][Full Text] [Related]
27. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
28. [Donor selection for the production of factor XIII preparations].
Uteg KH; Tausendfreund K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):447-55. PubMed ID: 2414175
[TBL] [Abstract][Full Text] [Related]
29. Plasmapheresis operations in the United States--1968.
Hartney JB
JAMA; 1970 Aug; 213(6):1023-5. PubMed ID: 5468172
[No Abstract] [Full Text] [Related]
30. Subthreshold reactive dysproteinemia in healthy subjects.
Szymik S
Mater Med Pol; 1975; 7(2):106-13. PubMed ID: 49462
[No Abstract] [Full Text] [Related]
31. [The indices of quality of the donor's plasma, obtained by the methods of plasmapheresis and primary fractionation, using various hemopreservatives and leukocytic filters].
Malyhon OI; Novak VL
Klin Khir; 2014 Apr; (4):43-5. PubMed ID: 25097977
[TBL] [Abstract][Full Text] [Related]
32. Short-term and long-term effects of plasmapheresis on serum proteins and immunoglobulins.
Friedman BA; Schork MA; Mocniak JL; Oberman HA
Transfusion; 1975; 15(5):467-72. PubMed ID: 53919
[TBL] [Abstract][Full Text] [Related]
33. [Effect of long-term plasmapheresis on blood composition. I. Changes in the concentration of total proteins, electrophoretic fractions and immunoglobulins].
Grgicević D; Pende B
Bilt Hematol Transfuz; 1981; 9(1-3):77-88. PubMed ID: 7349761
[TBL] [Abstract][Full Text] [Related]
34. EFFECTS OF INTENSIVE PLASMAPHERESIS ON NORMAL BLOOD DONORS.
KLIMAN A; CARBONE PP; GAYDOS LA; FREIREICH EJ
Blood; 1964 May; 23():647-56. PubMed ID: 14142503
[No Abstract] [Full Text] [Related]
35. Safety and long-term effects of plasmapheresis.
Cohen MA; Oberman HA
Transfusion; 1970; 10(2):58-66. PubMed ID: 4191819
[No Abstract] [Full Text] [Related]
36. Plasmapheresis-induced hemodilution and its effects on serum constituents.
Friedman BA; Schork MA; Alm SK; Jones AS; Oberman HA
Transfusion; 1976; 16(2):155-61. PubMed ID: 1258117
[TBL] [Abstract][Full Text] [Related]
37. Collection of source material from remunerated donors.
Rodell MB
Dev Biol Stand; 1993; 81():57-64. PubMed ID: 8174821
[TBL] [Abstract][Full Text] [Related]
38. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
Morse EE; Hohnadel DC; Genco P; Katz AJ
Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
[TBL] [Abstract][Full Text] [Related]
39. [Effect of plasmapheresis on the protein-synthetic function of the liver and several immunologic indices of reactivity of the donor organism].
Konstantinov VN
Probl Gematol Pereliv Krovi; 1970 Jul; 15(7):50-1. PubMed ID: 5484235
[No Abstract] [Full Text] [Related]
40. Making blood money safe and respectable.
White R
FDA Consum; 1975 Dec-1976 Jan; 9(10):11-9. PubMed ID: 10305009
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
